SUMMIT SMELLING SALTS- summit smelling salts inhalant 
Washburn Ventures LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Ammonia (15%)

Inhalant

To prevent or treat fainting.

WARNINGS: For external use only. Avoid contact with skin, eyes, and mouth.

if allergic, pregnant or have respiratory conditions.

INSTRUCTIONS:

1.Shake well before use.

2.Unscrew cap and hold at least 6 inches from nose.

3. Inhale slowly no more than 1-2 times per use.

4.Seal tightly and store in a dark, dry place at room temperature.

BEFORE USE:

Remove plastic seal, unscrew cap, and remove foil from mouth of bottle. Reseal lid after each use.

POTENCY PRESERVATION :

To maintain potency over time, always seal the lid tightly immediately after each use. Before each session, shake the bottle thoroughly to ensure optimal ammonia activation. For best experience, store the bottle in a dark, dry place at room temperature.

STOP USE AND ASK A DOCTOR if symptoms occur.

KEEP OUT OF REACH OF CHILDREN. If ingested, seek medical attention or contact Poison Control immediately.

DIRECTIONS: Hold bottle at least 6 inches from nose and inhale slowly no more than 1-2 times per use. Avoid repeated inhalationy

OTHER INFORMATION: Store at room temperature away from light and moisture.

Alcohol, Mint Flavor.

85764-001-01

SUMMIT SMELLING SALTS 
summit smelling salts inhalant
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:85764-001
Route of AdministrationRESPIRATORY (INHALATION)
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AMMONIA (UNII: 5138Q19F1X) (AMMONIA - UNII:5138Q19F1X) AMMONIA15 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
MINT (UNII: FV98Z8GITP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:85764-001-0140 g in 1 BOX; Type 0: Not a Combination Product06/04/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/04/2025
Labeler - Washburn Ventures LLC (136693055)
Establishment
NameAddressID/FEIBusiness Operations
Washburn Ventures LLC136693055manufacture(85764-001)

Revised: 6/2025
 
Washburn Ventures LLC